Varicella vaccine
واکسن آبلهمرغان
🦠 Antiinfectives For Systemic UseLive attenuated vaccine
Market / country: 🇺🇸 USA
Varivax (US)
🧮 Dose calculator
Immunisation (vaccination) · Regimen source: FDA Varivax · 2.1
- • Children: at least 3 months between doses. IM or SC. FDA Varivax · 2.1FDA Varivax · 2.3
Enter age (weight is optional for this regimen).
🛡️ Safety & information
Contraindications
- ⛔ Pregnancy, immunosuppression, moderate or severe febrile illness, active untreated tuberculosis (live vaccine). FDA Varivax · 4
- ⛔ Severe allergic reaction to a vaccine component (including gelatin and neomycin) or a previous dose. FDA Varivax · 4
Formulations
- 0.5 mL dose after reconstitution — injection 🇺🇸 USA FDA Varivax · 3
👥 Special populations
- 🤰 PregnancyContraindicated
Label: contraindicated in pregnancy. FDA Varivax · 4
“( 4.4 ) Pregnancy.”
- 🤱 BreastfeedingUse with caution
Label: use with caution while breastfeeding; see the label text. FDA Varivax · 8.2
“The developmental and health benefits of breastfeeding should be considered along with the mother's clinical need for VARIVAX, and any potential adverse effects on the breastfed child from VARIVAX or from the underlying maternal condition.”
- 👶 ChildrenUse with caution
The label has conditions, age limits or notes for children; the label sentence is quoted below. FDA Varivax · 8.4
“No clinical data are available on safety or efficacy of VARIVAX in children less than 12 months of age.”
- 👴 Older adultsUse with caution
Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Varivax · 8.5
“Clinical studies of VARIVAX did not include sufficient numbers of seronegative subjects aged 65 and over to determine whether they respond differently from younger subjects.”
- ⚥ Females & males of reproductive potentialNo data
The source for this drug has no section for this group.
🔗 Reference links
- FDA (approval record)BLA103552
- DailyMed (FDA label)FDA Varivax
- MedlinePlus (NIH)Varicella VaccineZoster Vaccine Live
- WHO ATC/DDDJ07BK01
- Darooyab (Iran)Varicella-Zoster-Vaccines
🇮🇷 Registered in Iran Darooyab · G-3537/Varicella-Zoster-Vaccines
Dosage forms with Iranian generic codes, per Darooyab.
- 01704 · VACCINE-VARICELLA (CHICKEN POX) AMP · آمپول واکسن–واریسللا (چیکن پوکس)
- 52630 · ZOSTER VACCINE, LIVE ATTENUATED INJECTION, POWDER, FOR SUSPENSION PARENTERAL 19400 [PFU]/0.65mL · پودر برای تهیه سوسپانسیون تزریقی واکسن زوستر زنده تضعیفشده ۱۹۴۰۰ PFU / ۰٫۶۵ میلیلیتر
- 53099 · ZOSTER VACCINE, RECOMBINANT INJECTION, POWDER, FOR SUSPENSION PARENTERAL 50 ug/0.5mL · پودر برای تهیه سوسپانسیون تزریقی واکسن زوستر نوترکیب ۵۰ میکروگرم / ۰٫۵ میلیلیتر
📚 Reference status for this drug
Shows which sources have references recorded for this drug and which do not.
- FDA label (DailyMed)✅ PresentFDA Varivax · 3FDA Varivax · 2.1FDA Varivax · 2.3FDA Varivax · 4FDA Varivax · 8.2FDA Varivax · 8.4FDA Varivax · 8.5FDA Varivax · SPL approval / marketing category
- UK SmPC (eMC / MHRA)❌ Not present
- Published guideline❌ Not present
- Licensed reference (medical school)❌ Not present
- Iranian leaflet (IFDA)❌ Not present
- Pharmacy website (secondary, unreliable)✅ PresentDarooyab · G-3537/Varicella-Zoster-Vaccines
- Clinical review⚠ Unverified